BioArctic AB (publ) (STO: BIOA.B)
Sweden
· Delayed Price · Currency is SEK 166.50
-7.30 (-4.20%)
Aug 30, 2024, 5:29 PM CET
BioArctic AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 299.35 | 616 | 228.29 | 23.15 | 62.35 | 281.77 | Upgrade
|
| Other Revenue | 2.5 | - | 1.14 | 2.52 | 2.86 | 1.17 | Upgrade
|
| Revenue | 301.85 | 616 | 229.43 | 25.66 | 65.21 | 282.94 | Upgrade
|
| Revenue Growth (YoY) | -51.08% | 168.49% | 794.02% | -60.64% | -76.95% | -60.82% | Upgrade
|
| Cost of Revenue | 67.18 | 89.63 | 74.33 | 55.07 | 50.24 | 72.42 | Upgrade
|
| Gross Profit | 234.67 | 526.37 | 155.11 | -29.4 | 14.96 | 210.52 | Upgrade
|
| Selling, General & Admin | 211.59 | 251.25 | 148.67 | 97.35 | 86.35 | 90.88 | Upgrade
|
| Research & Development | 99.2 | - | - | - | - | - | Upgrade
|
| Other Operating Expenses | 4.7 | -0.27 | -0.25 | -0.01 | -0.08 | -0.65 | Upgrade
|
| Operating Expenses | 329.35 | 269.41 | 163.04 | 110.45 | 97.28 | 99.43 | Upgrade
|
| Operating Income | -94.68 | 256.96 | -7.94 | -139.85 | -82.32 | 111.09 | Upgrade
|
| Interest Expense | - | -0.33 | -0.56 | -0.84 | -0.98 | -1.19 | Upgrade
|
| Interest & Investment Income | 22.64 | 34.23 | 2.54 | - | 0.01 | 0.25 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.34 | -14.32 | -5.01 | 0.33 | -3.07 | 2.83 | Upgrade
|
| Other Non Operating Income (Expenses) | 22.4 | -0.05 | -0.19 | -0.15 | -0.11 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -60.97 | 276.49 | -11.17 | -140.5 | -86.48 | 112.98 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.01 | -0.21 | - | Upgrade
|
| Pretax Income | -60.97 | 276.49 | -11.17 | -140.51 | -86.69 | 112.98 | Upgrade
|
| Income Tax Expense | 27.31 | 47.24 | 0.01 | -20.72 | -18.17 | 24.51 | Upgrade
|
| Net Income to Company | - | 229.25 | -11.18 | -119.79 | -68.52 | 88.47 | Upgrade
|
| Net Income | -88.28 | 229.25 | -11.18 | -119.79 | -68.52 | 88.47 | Upgrade
|
| Net Income to Common | -88.28 | 229.25 | -11.18 | -119.79 | -68.52 | 88.47 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -76.82% | Upgrade
|
| Shares Outstanding (Basic) | 88 | 88 | 88 | 88 | 88 | 88 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 88 | 89 | 88 | 88 | 88 | Upgrade
|
| Shares Change (YoY) | -0.65% | -0.22% | 0.71% | - | - | - | Upgrade
|
| EPS (Basic) | -1.00 | 2.60 | -0.13 | -1.36 | -0.78 | 1.00 | Upgrade
|
| EPS (Diluted) | -1.00 | 2.59 | -0.13 | -1.36 | -0.78 | 1.00 | Upgrade
|
| EPS Growth | - | - | - | - | - | -76.91% | Upgrade
|
| Free Cash Flow | -140.75 | 302.25 | -44.38 | -144.84 | -104.81 | 323.9 | Upgrade
|
| Free Cash Flow Per Share | -1.60 | 3.42 | -0.50 | -1.64 | -1.19 | 3.68 | Upgrade
|
| Gross Margin | 77.74% | 85.45% | 67.60% | -114.58% | 22.95% | 74.40% | Upgrade
|
| Operating Margin | -31.37% | 41.71% | -3.46% | -544.96% | -126.24% | 39.26% | Upgrade
|
| Profit Margin | -29.25% | 37.22% | -4.87% | -466.78% | -105.08% | 31.27% | Upgrade
|
| Free Cash Flow Margin | -46.63% | 49.07% | -19.34% | -564.40% | -160.74% | 114.48% | Upgrade
|
| EBITDA | -76.03 | 275.39 | -1.87 | -134.72 | -78.49 | 114.05 | Upgrade
|
| EBITDA Margin | -25.19% | 44.71% | -0.82% | - | -120.37% | 40.31% | Upgrade
|
| D&A For EBITDA | 18.65 | 18.43 | 6.07 | 5.13 | 3.83 | 2.96 | Upgrade
|
| EBIT | -94.68 | 256.96 | -7.94 | -139.85 | -82.32 | 111.09 | Upgrade
|
| EBIT Margin | -31.37% | 41.71% | -3.46% | - | -126.24% | 39.26% | Upgrade
|
| Effective Tax Rate | - | 17.08% | - | - | - | 21.69% | Upgrade
|
| Revenue as Reported | - | -620.08 | -228.63 | 26.69 | 65.94 | 296.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.